fenofibrate has been researched along with methylcellulose in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, RR; Ilasi, N; Sekulic, SS; Zelesky, T | 1 |
| Chai, G; He, H; Tang, X; Xu, H; Zeng, X; Zhang, L | 1 |
| Dong, Y; Hu, J; Ng, WK; Shen, S; Tan, RB | 1 |
| Meng, X; Mitra, S; Romanski, FS; Tomassone, MS; Zhu, W | 1 |
| Bhakay, A; Bilgili, E; Davé, RN; Iqbal, Z; Jerez-Rozo, JI; Michniak-Kohn, B; Pandya, N; Romañach, RJ; Sievens-Figueroa, L | 1 |
| Fischbach, M; Kalivoda, A; Kleinebudde, P | 1 |
| Birk, G; Dressman, JB; Herbert, E; Lubda, D; Saal, C; Wieber, A | 1 |
| Dressman, JB; Griffin, BT; Herbert, E; Lubda, D; Nagarsekar, K; O'Driscoll, CM; O'Shea, JP; Saal, C; Wieber, A; Witt, V | 1 |
8 other study(ies) available for fenofibrate and methylcellulose
| Article | Year |
|---|---|
Simultaneously measuring concentrations of a model drug and a model excipient in solution using ultrasonic spectrometry.
Topics: Drug Compounding; Excipients; Fenofibrate; Kinetics; Linear Models; Methylcellulose; Pharmaceutical Preparations; Quality Control; Solutions; Spectrum Analysis; Temperature; Ultrasonics; Water | 2005 |
Preparation of fenofibrate immediate-release tablets involving wet grinding for improved bioavailability.
Topics: Administration, Oral; Animals; Biological Availability; Dogs; Drug Carriers; Drug Compounding; Drug Stability; Excipients; Fenofibrate; Hypolipidemic Agents; Hypromellose Derivatives; Methylcellulose; Particle Size; Solubility; Suspensions; Tablets; Therapeutic Equivalency | 2010 |
Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
Topics: Calorimetry, Differential Scanning; Chemical Precipitation; Chemistry, Pharmaceutical; Crystallization; Drug Compounding; Excipients; Feasibility Studies; Fenofibrate; Hypolipidemic Agents; Hypromellose Derivatives; Kinetics; Lactose; Light; Mannitol; Methylcellulose; Microscopy, Electron, Scanning; Nanoparticles; Nanotechnology; Polysorbates; Powders; Scattering, Radiation; Sodium Dodecyl Sulfate; Solubility; Solvents; Surface Properties; Technology, Pharmaceutical; X-Ray Diffraction | 2011 |
Atomistic simulation study of surfactant and polymer interactions on the surface of a fenofibrate crystal.
Topics: Crystallization; Drug Stability; Excipients; Fenofibrate; Glucans; Hypromellose Derivatives; Methylcellulose; Models, Chemical; Models, Molecular; Molecular Structure; Polymers; Polysorbates; Sodium Dodecyl Sulfate; Solubility; Surface Properties; Surface-Active Agents; Technology, Pharmaceutical | 2011 |
Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
Topics: Chemistry, Pharmaceutical; Crystallization; Crystallography, X-Ray; Drug Carriers; Drug Compounding; Elastic Modulus; Feasibility Studies; Fenofibrate; Glycerol; Griseofulvin; Hydrogen Bonding; Hypromellose Derivatives; Kinetics; Methylcellulose; Microscopy, Electron, Scanning; Nanoparticles; Nanotechnology; Naproxen; Particle Size; Plasticizers; Solubility; Spectroscopy, Near-Infrared; Spectrum Analysis, Raman; Surface Properties; Surface-Active Agents; Technology, Pharmaceutical | 2012 |
Application of mixtures of polymeric carriers for dissolution enhancement of fenofibrate using hot-melt extrusion.
Topics: Calorimetry, Differential Scanning; Crystallization; Drug Carriers; Drug Compounding; Drug Stability; Drug Storage; Fenofibrate; Hypromellose Derivatives; Methylcellulose; Polyethylene Glycols; Polymers; Polyvinyls; Pyrrolidines; Solubility; Vinyl Compounds; X-Ray Diffraction | 2012 |
Mesoporous silica-based dosage forms improve release characteristics of poorly soluble drugs: case example fenofibrate.
Topics: Delayed-Action Preparations; Drug Compounding; Fasting; Fenofibrate; Gastric Juice; Hypolipidemic Agents; Hypromellose Derivatives; Intestinal Secretions; Kinetics; Methylcellulose; Models, Chemical; Nanoparticles; Particle Size; Porosity; Povidone; Pyrrolidines; Silicon Dioxide; Solubility; Technology, Pharmaceutical; Vinyl Compounds | 2016 |
Mesoporous silica-based dosage forms improve bioavailability of poorly soluble drugs in pigs: case example fenofibrate.
Topics: Administration, Oral; Animals; Biological Availability; Dosage Forms; Fenofibrate; Hypolipidemic Agents; Male; Methylcellulose; Porosity; Silicon Dioxide; Solubility; Swine | 2017 |